Lumosa Therapeutics Co., Ltd. (TPEX: 6535)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
247.00
-1.00 (-0.40%)
Sep 10, 2024, 1:30 PM CST

Lumosa Therapeutics Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
289.99425.25516.85840.32898.64168.8
Upgrade
Short-Term Investments
319.06419.06667.67589.89372.26456.2
Upgrade
Trading Asset Securities
---21.89--
Upgrade
Cash & Short-Term Investments
609.05844.311,1851,4521,271625.01
Upgrade
Cash Growth
-39.08%-28.72%-18.43%14.26%103.34%-31.11%
Upgrade
Accounts Receivable
9.212149.6913.84289.06
Upgrade
Other Receivables
17.8818.1317.9817.0116.3819.57
Upgrade
Receivables
27.0830.1431.9826.730.22308.62
Upgrade
Inventory
103.39103.91108.6882.3931.7824
Upgrade
Prepaid Expenses
66.8365.6660.8859.1713.655.97
Upgrade
Other Current Assets
1.420.02-0.130.021.8
Upgrade
Total Current Assets
807.761,0441,3861,6201,347965.4
Upgrade
Property, Plant & Equipment
23.8227.537.661319.516.75
Upgrade
Long-Term Investments
763.84583.79464.72671.32246.72145.11
Upgrade
Goodwill
----78.4978.49
Upgrade
Other Intangible Assets
0.540.626.9343.5792.72118.25
Upgrade
Other Long-Term Assets
0.320.320.320.320.320.32
Upgrade
Total Assets
1,5961,6561,8862,3491,7841,324
Upgrade
Accounts Payable
0.2715.3112.2514.50.037.84
Upgrade
Accrued Expenses
33.6734.8433.6243.2628.6882.15
Upgrade
Current Portion of Leases
4.154.494.335.45.837.44
Upgrade
Current Income Taxes Payable
-----13.57
Upgrade
Current Unearned Revenue
3.043.046.884.680.32-
Upgrade
Other Current Liabilities
156.17161.9158.28156.18155.65163.17
Upgrade
Total Current Liabilities
197.31219.58215.36224.03190.5274.17
Upgrade
Long-Term Leases
6.398.120.366.0811.134.27
Upgrade
Total Liabilities
203.7227.69215.72230.11201.63278.44
Upgrade
Common Stock
1,6501,6501,6311,6321,4741,176
Upgrade
Additional Paid-In Capital
1,3601,3631,2681,271963.36402.09
Upgrade
Retained Earnings
-1,542-1,494-1,256-761.44-857.38-534.82
Upgrade
Comprensive Income & Other
-99.33-117.45-13.53-22.982.962.96
Upgrade
Total Common Equity
1,3681,4011,6302,1191,5831,046
Upgrade
Minority Interest
24.2327.8940.18---
Upgrade
Shareholders' Equity
1,3931,4291,6702,1191,5831,046
Upgrade
Total Liabilities & Equity
1,5961,6561,8862,3491,7841,324
Upgrade
Total Debt
10.5412.614.6911.4916.9511.71
Upgrade
Net Cash (Debt)
598.5831.71,1801,4411,254613.3
Upgrade
Net Cash Growth
-39.99%-29.51%-18.10%14.89%104.46%-32.40%
Upgrade
Net Cash Per Share
3.685.127.269.5510.385.23
Upgrade
Filing Date Shares Outstanding
164.93164.97163.1163.15147.37117.56
Upgrade
Total Common Shares Outstanding
164.93164.97163.1163.15147.37117.56
Upgrade
Working Capital
610.46824.461,1711,3961,156691.23
Upgrade
Book Value Per Share
8.308.499.9912.9910.748.90
Upgrade
Tangible Book Value
1,3681,4001,6032,0751,411849.14
Upgrade
Tangible Book Value Per Share
8.298.499.8312.729.587.22
Upgrade
Machinery
41.9541.531.8229.5329.5331.18
Upgrade
Leasehold Improvements
3.213.21--0.242.07
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.